Evidence map›Paper›PMID 29104783›Full record

ArticleActa naturae

Expression Levels of the Uridine-Cytidine Kinase Like-1 Protein As a Novel Prognostic Factor for Hepatitis C Virus-Associated Hepatocellular Carcinomas.

A Buivydiene, V Liakina, J Valantinas, J Norkuniene, E Mockiene, S Jokubauskiene, R Smaliukiene, L Jancoriene, L Kovalevska, E Kashuba

Open access · bronzeAbstract read
In one paragraph

Article in Acta naturae. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.1field-weighted citation impact, top 46% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 3 countries.

A BuivydieneVilnius University, Clinic of Gastroenterology, Nephrourology and Surgery, Centre of Hepatology, Gastroenterology and Dietetics, Vilnius, Lithuania.
V LiakinaVilnius University, Center of Hepatology, Gastroenterology and Dietetics, Vilnius, Lithuania.
J ValantinasVilnius University, Clinic of Gastroenterology, Nephrourology and Surgery, Centre of Hepatology, Gastroenterology and Dietetics, Vilnius, Lithuania.
J NorkunieneVilnius Gediminas Technical University, Department of Mathematical Statistics, Vilnius, Lithuania.
E MockieneCentre of Radiology and Nuclear Medicine, Vilnius, Lithuania.
S JokubauskieneVilnius University, Department of Pathology, Forensic Medicine and Pharmacology, Vilnius, Lithuania.
R SmaliukieneNational Center of Pathology, Vilnius, Lithuania.
L JancorieneVilnius University, Clinic of Infectious, Chest Diseases, Dermatovenerology and Allergy, Center of Infectious Diseases, Vilnius, Lithuania.
L KovalevskaR.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kyiv, Ukraine.
E KashubaR.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology, Kyiv, Ukraine.
Vilnius University · LTR.E. Kavetsky Institute of Experimental Pathology, Oncology and Radiobiology · UAVilnius University of Applied Sciences · LT

Funding

EPA EP-C-15-003
6 · The paper itself

Abstract

The expression levels of the two novel oncoproteins uridine-cytidine kinase like-1 (UCKL-1) and mitochondrial ribosomal protein S18-2 (MRPS18-2) were assessed in samples of hepatitis C virus (HCV)-associated hepatocellular carcinoma (HCC) using immunohistochemistry. Tissue microarray (TMA) paraffin blocks were prepared from 42 HCC tumor samples with the corresponding peri-tumor tissues and from 11 tissues of a liver with HCV-induced cirrhosis. We found that the UCKL-1 signal in the liver tissues of the peri-tumor zone in the HCC samples was stronger than that in cirrhosis (50 ± 49.44 vs. 24.27 ± 14.53;

Indexed as

hepatitis C virus (HCV)hepatocellular carcinoma (HCC)MRPS18-2prognostic factorsrecurrence of hepatocellular carcinomaUCKL-1

Identifiers

PMID29104783
PMCPMC5662281
OpenAlexW2775217951

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.